Gene Expression Analysis Market

Thermo Fisher Scientific Inc. (US) and Bio-Rad Laboratories, Inc. (US) are Leading Players in the Gene Expression Analysis Market

The gene expression analysis market is projected to reach USD 6.2 billion by 2029 from an estimated USD 4.2 billion in 2024, at a CAGR of 8.1% during the forecast period. The major factors driving the growth of this gene expression analysis market include growing advancements in gene editing technologies, increasing funding initiatives for genomic research, and growing preference for therapeutic medicines.

The global gene expression analysis market is consolidated with top players such as Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), and Bio-Rad Laboratories, Inc. (US). The market players have adopted various strategies such as new product launches, acquisitions, agreements, collaborations, partnerships, and geographical expansions to strengthen their position in the global gene expression analysis market.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific is a leading science & technology company manufacturing high-end analytical instruments, laboratory equipment, software, consumables, reagents, and services for scientific research, analysis, discovery, and diagnostics. The company operates in the gene expression analysis market through its Life Sciences Solutions segment. The company serves its customers through premier brands: Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. The firm has a strong foothold in more than 50 countries worldwide, owing to a strong sales and distribution network. The company is expanding its business through inorganic growth strategies. For instance, In May 2023, Thermo Fisher Scientific and Pfizer collaborated to expand localized access to Next-generation Sequencing-based testing for cancer patients in over 30 countries across Latin America, Africa, the Middle East, and Asia.

Bio-Rad Laboratories, Inc. (US)

Bio-Rad Laboratories is a renowned manufacturer and provider of products and services for the life sciences research and clinical diagnostics markets. The company develops and delivers various products for life science research, healthcare, analytical chemistry, and other markets. The company offers gene expression analysis products through the Life Sciences segment. The company is focused on upgrading its technology platform for gene expression analysis products. Additionally, the company has a strong geographic presence worldwide with global distribution channels  The company is expanding its presence in the market by implying inorganic growth strategies. For instance, in August 2022, Bio-Rad Laboratories Inc. acquired Curiosity Diagnostics to expand its capabilities by inculcating a new generation of rapid PCR systems into its product portfolio.

Illumina, Inc. (US)

Illumina is a molecular diagnostics company that develops, manufactures, and markets integrated systems to analyze genetic variations and biological functions. The company is renowned for its next-generation sequencing industry with its platforms and associated products. The company’s portfolio includes integrated systems, consumables, and analysis tools to simplify genetic analysis. Illumina also offers software and informatics platforms, including cloud-based computational tools, for its sequencing and array-based systems. The company’s growth strategy relies on its core Illumina and GRAIL business segments since it focuses on technical innovations for improved product efficiency. The company also invests in incorporating cutting-edge technologies into its business segment to enhance capabilities in the gene expression analysis market. The company also focuses on organic strategies, such as expansions, to strengthen its position in the market. For instance, in April 2022, Illumina established a new state-of-the-art facility solution center in São Paulo, Brazil, to expand global access to genomics in Latin America. Illumina’s revenue is majorly generated from markets across North America, Europe, the Middle East, and Africa.

Related Reports:

Gene Expression Analysis Market by Product (Reagents, Enzymes, kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & development, clinical diagnostics), End User - Global Forecast to 2029

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Gene Expression Analysis Market Size,  Share & Growth Report
Report Code
BT 2236
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status